Moderna and Merck Achieve Cancer Vaccine Breakthrough After Decades of Failure

Moderna and Merck have achieved a cancer vaccine breakthrough after a century of failures in the field. Stephane Bancel, CEO of Moderna, received a call while celebrating a friend's birthday at a Lebanese restaurant on August 13.

The companies' collaboration has led to a successful trial of their mRNA-based cancer vaccine. This achievement comes after decades of research and failed attempts by pharmaceutical companies to develop an effective cancer vaccine.

Moderna's CEO, Stephane Bancel, spoke about the significance of this breakthrough, but no specific details were mentioned in the source article.